|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C12N 15/62 | (2006.01) |
| C07K 14/33 | (2006.01) | ||
| A61K 39/08 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 16/12 | (2006.01) | ||
| C12N 15/70 | (2006.01) |
| (11) | Number of the document | 3564378 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19179871.9 |
| Date of filing the European patent application | 2012-05-25 | |
| (97) | Date of publication of the European application | 2019-11-06 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-01 |
| (46) | Date of publication of the claims translation | 2024-01-25 |
| (30) | Number | Date | Country code |
| 201161490707 P | 2011-05-27 | US | |
| 201161490734 P | 2011-05-27 | US | |
| 201161490716 P | 2011-05-27 | US |
| (72) |
CASTADO, Cindy , BE
|
| (73) |
GlaxoSmithKline Biologicals SA ,
Rue de l'Institut, 89, 1330 Rixensart,
BE
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Imunogeninė kompozicija |
| IMMUNOGENIC COMPOSITION |
| Payment date | Validity (years) | Amount | |
| 2024-04-18 | 13 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2024-12-12 |